Here we present a report of a statistically significant association between the loss of GSTPi expression in breast cancer cells and the maintenance of its expression in vimentin/α-SMA-positive CAF in tumour microenvironment in paired cases of primary invasive breast cancer and corresponding axillary lymph node metastases. The gene discussed is VIM; the disease is breast cancer.